-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
IgA nephropathy, also known as Berger's disease, is the most common primary glomerulonephritis and chronic glomerular disease in the wor.
Proteinuria has been recognized as a risk factor for decreased renal function and poor prognosis in IgA nephropathy in renal disea.
Hydroxychloroquine (HCQ) is considered an immunomodulatory and anti-inflammatory age.
Flowchart of path selection:
Methods: PubMed and Embase were systematically searched for studies through June 2021 comparing HCQ and other treatments to reduce proteinuria in patients with IgA nephropat.
method:
Forest plot comparing percent proteinuria reduction for HCQ and controls:
Forest plot comparing percent proteinuria reduction for HCQ and controls:RESULTS: A total of 5 studies with 587 participants were includ.
result:
Forest plot comparing mean proteinuria levels at 6 months between HCQ and controls:
Forest plot comparing mean proteinuria levels at 6 months between HCQ and controls:In conclusion, HCQ has a mild antiproteinuric effect in patients with IgA nephropathy
HCQ has mild antiproteinuric effect in patients with IgA nephropathy
Reference: Zhang J, Lu X, Feng J, Li H, Wang.
Reference: Zhang J, Lu X, Feng J, Li H, Wang.
Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Systematic Review and Meta-Analys.
Biomed Res I.
2021 Dec 3;2021:917171 doi: 11155 /2021/917171 PMID: 34901280; PMCID: PMC866453 Leave a message here